Joerg Kumbrink
Postdoctoral Associate
Boston University School of Medicine
Dept of Biochemistry



Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

  1. Kumbrink J, de la Cueva A, Soni S, Sailer N, Kirsch KH. A truncated phosphorylated p130Cas substrate domain is sufficient to drive breast cancer growth and metastasis formation in vivo. Tumour Biol. 2016 Aug; 37(8):10665-73.View Related Profiles. PMID: 26867768; DOI: 10.1007/s13277-016-4902-8;.
  2. Rouka E, Simister PC, Janning M, Kumbrink J, Konstantinou T, Muniz JR, Joshi D, O'Reilly N, Volkmer R, Ritter B, Knapp S, von Delft F, Kirsch KH, Feller SM. Differential Recognition Preferences of the Three Src Homology 3 (SH3) Domains from the Adaptor CD2-associated Protein (CD2AP) and Direct Association with Ras and Rab Interactor 3 (RIN3). J Biol Chem. 2015 Oct 16; 290(42):25275-92.View Related Profiles. PMID: 26296892; PMCID: PMC4646179; DOI: 10.1074/jbc.M115.637207;.
  3. Kumbrink J, Soni S, Laumbacher B, Loesch B, Kirsch KH. Identification of Novel Crk-associated Substrate (p130Cas) Variants with Functionally Distinct Focal Adhesion Kinase Binding Activities. J Biol Chem. 2015 May 8; 290(19):12247-55.View Related Profiles. PMID: 25805500; PMCID: PMC4424356; DOI: 10.1074/jbc.M115.649947;.
  4. Chakrabarti P, Kim JY, Singh M, Shin YK, Kim J, Kumbrink J, Wu Y, Lee MJ, Kirsch KH, Fried SK, Kandror KV. Insulin inhibits lipolysis in adipocytes via the evolutionarily conserved mTORC1-Egr1-ATGL-mediated pathway. Mol Cell Biol. 2013 Sep; 33(18):3659-66.View Related Profiles. PMID: 23858058; PMCID: PMC3753874; DOI: 10.1128/MCB.01584-12;.
  5. Zhao Y, Kumbrink J, Lin BT, Bouton AH, Yang S, Toselli PA, Kirsch KH. Expression of a phosphorylated substrate domain of p130Cas promotes PyMT-induced c-Src-dependent murine breast cancer progression. Carcinogenesis. 2013 Dec; 34(12):2880-90.View Related Profiles. PMID: 23825155; PMCID: PMC3845889; DOI: 10.1093/carcin/bgt238;.
  6. Kumbrink J, Kirsch KH. p130Cas acts as survival factor during PMA-induced apoptosis in HL-60 promyelocytic leukemia cells. Int J Biochem Cell Biol. 2013 Mar; 45(3):531-5.View Related Profiles. PMID: 23287717; DOI: 10.1016/j.biocel.2012.12.017;.
  7. Kumbrink J, Kirsch KH. Regulation of p130(Cas)/BCAR1 expression in tamoxifen-sensitive and tamoxifen-resistant breast cancer cells by EGR1 and NAB2. Neoplasia. 2012 Feb; 14(2):108-20.View Related Profiles. PMID: 22431919; PMCID: PMC3306256.
  8. Kumbrink, J and Kirsch, KH. Breast Cancer - Current and Alternative Therapeutic Modalities. Esra Gunduz and Mehmet Gunduz (Ed.). Targeting Cas Family Proteins as a Novel Treatment for Breast Cancer. InTech. 2011; 37-62. View Publication
  9. Kumbrink J, Kirsch KH, Johnson JP. EGR1, EGR2, and EGR3 activate the expression of their coregulator NAB2 establishing a negative feedback loop in cells of neuroectodermal and epithelial origin. J Cell Biochem. 2010 Sep 1; 111(1):207-17.View Related Profiles. PMID: 20506119; PMCID: PMC2930072; DOI: 10.1002/jcb.22690;.
  10. Kumbrink J, Gerlinger M, Johnson JP. Egr-1 induces the expression of its corepressor nab2 by activation of the nab2 promoter thereby establishing a negative feedback loop. J Biol Chem. 2005 Dec 30; 280(52):42785-93. PMID: 16260776.

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 10 publications over 7 distinct years, with a maximum of 2 publications in 2012 and 2013 and 2015

YearPublications
20051
20101
20111
20122
20132
20152
20161
Contact for Mentoring:


72 E. Concord St Silvio Conte (K)
Boston MA 02118
Google Map


Kumbrink's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Co-Authors
_
Similar People
_